The newly diagnosed acute myeloid leukemia registry and ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) sample collections for further investigating about molecular mutations

Status

Recruiting

Phases

Unknown

Study type

Observational

Source

TCTR

Registry ID

TCTR20201027001

Enrollment

139

Registered

2020-10-27

Start date

2020-10-21

Completion date

Unknown

Last updated

2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

The patients 18 years and older who were diagnosis and known to have acute leukemia Myeloid. Acute leukemia Myeloid &#44

Interventions

Thai patient newly diagnosed acute leukemia Myeloid Age group 18 years and over between 1 March 2018 and 31 December 2022

Diagnostic

The patients 18 years and older who were diagnosis.

Eligibility

Sex/Gender

All

Age

18 Years to No maximum

Inclusion criteria

Inclusion criteria: Thai patient newly diagnosed acute leukemia Myeloid Age group 18 years and over between 1 March 2018 and 31 December 2022 and participate sign ICF.

Exclusion criteria

Exclusion criteria: The patients with hemoglobin level less than 5 g / dl. and the patients with insufficient amount of radiosurgery needed for standard screening.

Design outcomes

Primary

Measure	Time frame
Incidence of acute myeloid leukemia in Thailand 2 years Number leukocytes in AML patients per normal population	—

Secondary

Measure	Time frame
Incidence of ribonucleic acid (RNA) and deoxyribonucleic acid (DNA) in acute myeloid leukemia 2 years Number ribonucleic acid (RNA) and deoxyribonucleic acid (DNA)	—

Countries

Thailand

Contacts

Public ContactWeerapat Owattanapanich

Division of Hematology, Department of Medicine, Faculty of Medicine, Siriraj Hospital, Mahidol Unive

weerapato36733@gmail.com089-108-1983

Outcome results

None listed

Source: TCTR (via WHO ICTRP) · Data processed: Aug 9, 2026